key: cord-0782757-ga380bwm
authors: Gao, Bingtao; Rojas Chavez, Anthony A.; Malkawi, Walla I.; Keefe, Daniel W.; Smith, Rasheid; Haim, Hillel; Salem, Aliasger K.; Toor, Fatima
title: Sensitive detection of SARS-CoV-2 spike protein using vertically-oriented silicon nanowire array-based biosensor
date: 2022-03-22
journal: Sens Biosensing Res
DOI: 10.1016/j.sbsr.2022.100487
sha: c4b208b5590cf59c95384faca8fa93993c68a4ba
doc_id: 782757
cord_uid: ga380bwm

The COVID-19 pandemic has caused tremendous damage to the world. In order to quickly and accurately diagnose the virus and contain the spread, there is a need for rapid, sensitive, accurate, and cost-effective SARS-CoV-2 biosensors. In this paper, we report on a novel biosensor based on angiotensin converting enzyme 2 (ACE-2)-conjugated vertically-oriented silicon nanowire (vSiNW) arrays that can detect the SARS-CoV-2 spike protein with high sensitivity and selectivity relative to negative controls. First, we demonstrate the efficacy of using ACE-2 receptor to detect the SARS-CoV-2 spike protein via a capture assay test, which confirms high specificity of ACE-2 against the mock protein, and high affinity between the spike and ACE-2. We then report on results for ACE-2-conjugated vSiNW arrays where the biosensor device architecture is based on a p-n junction transducer. We confirm via analytical modeling that the transduction mechanism of the biosensor involves induced surface charge depletion of the vSiNWs due to negative electrostatic surface potential induced by the spike protein after binding with ACE-2. This vSiNW surface charge modulation is measured via current-voltage characteristics of the functionalized biosensor. Calibrated concentration dependent electrical response of the vSiNW sensor confirms the limit-of-detection for virus spike concentration of 100 ng/mL (or 575 pM). The vSiNW sensor also exhibits highly specific response to the spike protein with respect to negative controls, offering a promising point-of-care detection method for SARS-CoV-2.

Coronavirus disease 2019 (COVID-19) is a human infectious disease emerged in late 2019 that is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Based on the rapid increase in human infection, the World Health Organization has classified the COVID-19 outbreak as a pandemic. Among people without vaccination or immunity, early diagnosis and containment are critical for limiting the spread of the virus [1] . One approach to detect SARS-CoV-2 infection is the reverse transcription polymerase chain reaction (RT-PCR) using nasopharyngeal (NP) or throat swab samples [2] . It involves incubation, RNA extraction, reverse transcriptase, PCR amplification, and spectrophotometry [3] . This approach has good specificity but intermediate sensitivity, with false-negative rates ranging between 4% and 29% [4, 5] . In particular, the sensitivity and false-negative rates can aggravate five days after symptom onset [6, 7] . According to the Center for Disease Control [8] , while RT-PCR based tests are highly specific and sensitive, they are costly (~$75-$100/test) with moderate to high complexity sample processing requiring trained professional staff, and the turnaround time for results could range from several hours to 1-3 days. The considerable lag between sample collection and the time individuals are informed of the results is a major concern and can lead to preventable spread of SARS-CoV-2. RT-PCR based tests also require Clinical Laboratory Improvement Amendments (CLIA) certification which can be costly to obtain and maintain for resource constrained rural clinics [9] .

Several inexpensive point-of-care (POC) antigen-detection rapid diagnostic tests (Ag-RDTs) are currently commercially available. World Health Organization (WHO) recommends minimum sensitivity of 80% and specificity of 97% for Ag-RDTs [10] . Peeling et al. [11] reported in an J o u r n a l P r e -p r o o f extensive global study of Ag-RDTs that almost all of the single antigen tests for SARS-CoV-2 meet the WHO criteria. WHO recognizes that despite lower sensitivity than RT-PCR tests, Ag-RDTs offer the possibility of rapid, inexpensive detection of SARS-CoV-2 in individuals who have high viral loads and hence are at high risk of transmitting the infection to others. However, some key shortcomings are that Ag-RDTs are typically non-modular i.e., are designed to detect only one virus, and cannot differentiate between SARS-CoV-2 and other common respiratory viruses. Ag-RDTs tests also only provide qualitative results with limited ability to identify the stage of infection.

Alternatively, recently there has been increasing efforts in the development of angiotensinconverting enzyme 2 (ACE2) receptor-based biosensors by multiple research groups around the world [12] [13] [14] [15] [16] . This is because ACE2 is the main receptor used by SARS-CoV-2 for cellular entry, and infection of SARS-CoV-2 begins when the spike protein binds to ACE2 [17] . In a recent study, Ozono et al. [18] reported the binding affinity of ACE2 with five variants having global spread and mutations in the spike protein, and noted that four out of five variants showed significantly increased binding affinity to ACE2. From these results, one can infer that variants with a higher binding affinity to ACE2 are more contagious. Accordingly, implementing ACE2 in a biosensor can be an effective strategy for screening variants with high transmissibility.

Recently Park et al. [13] demonstrated a high sensitivity (~165 virus copies/mL) dual-gate fieldeffect transistor (FET) using ACE2 as the receptor. However, the dual-gate FET architecture was rather complex to manufacture and based on non-CMOS compatible materials, such as tin oxide, titanium nitride, among others; all of which can make it challenging to scale up this biosensor architecture for global monitoring of the pandemic. The work also did not confirm selective detection of the spike with respect to negative controls. Another biosensor architecture was reported by Pinals et al. [15] based on ACE2-single-walled carbon nanotube (SWCNT) optical sensing. The team demonstrated that the ACE2-SWCNT nanosensors exhibit a 73% fluorescence turn-on response within 5 seconds of exposure to 35 mg/L SARS-CoV-2 virus-like particles.

SWCNTs are expensive and spectroscopic measurements needed for the optical characterization require bulky equipment that renders this sensor architecture unsuitable for inexpensive portable biosensors.

In this manuscript, we present results on a scalable bioelectronic sensor platform, which converts the binding of target biomolecules to electrical signals in a rapid and compact formfactor, enabling POC testing of viruses, such as COVID-19, by minimally trained individuals qualifying it for eventual CLIA waiver certification. Our biosensor architecture is based on silicon nanowires (SiNWs) that various teams [19, 20] including ours [21] have demonstrated to have higher sensitivity than planar Si biosensors because of the high surface-to-volume ratio of the SiNWs. However, not all SiNWs-based biosensors are suited for COVID-19 detection, because their manufacturing steps are not complementary metal oxide semiconductor (CMOS) compatible while also being low-yield, slow, and require high-cost equipment [22] [23] [24] [25] . To address these challenges of SiNWs-based biosensors, we employ the metal-assisted chemical etching (MACE) process [26, 27] to fabricate large area arrays of vertically-oriented SiNWs (vSiNWs) for our biosensor. The MACE process is CMOS-compatible and does not require any vacuum-based equipment and can be scaled up cost-effectively. Fig. S1 shows the scanning electron microscope images of the resulting vSiNWs from the MACE process. After the vSiNW MACE etching, the Si substrate is turned into an electrically active p-n junction diode via a number of nanofabrication steps shown in Fig. S1 . Our simple device architecture allows us to electrically probe millions of NWs concurrently via a top and bottom contact scheme ( Fig. 1(c) ), and since each NW acts as an anchor for the target molecule, the sensor architecture results in highly sensitive detection of the biomolecules.

We functionalized the vSiNWs-based biosensors for SARS-CoV-2 detection by first treating the sensor surface with (3-Aminopropyl) triethoxysilane (APTES) and then immobilizing human angiotensin converting enzyme 2 (ACE-2) on APTES. Since ACE-2 interacts with the spike protein of SARS-CoV-2 with high affinity [28] , we decided to utilize this interaction to detect presence of the virus. The spike protein is on the surface of SARS-CoV-2 molecule, and the specific binding of spike and ACE-2 proteins is found to be critical to the immobilization of SARS-CoV-2 during the infection of human cells [29] . A similar biochemical process was simulated on the surface of vSiNWs when the ACE-2 functionalized sensor was immersed in the solution of spike protein. We expect the polar spike protein to induce an electrostatic surface potential that can modulate the carrier density of vSiNWs substantially [30] , as shown in Fig.   1(a) . The detection of the coronavirus was thereby enabled by the conversion of this charge density modulation in the n-doped vSiNWs, into an electrical signal. Relative to RT-PCR, J o u r n a l P r e -p r o o f advantages of the vSiNW sensor platform are manifold, including: (i) results are obtained within one hour, allowing rapid containment of infected individuals, (ii) due to the low expense of fabricating Si devices, the cost of each sensor is expected to be $10 to $15 (at scale production of 100,000 sensors/year), (iii) the sensor is small and portable, and can be used in a wide range of public settings for on-the-spot results, and (iv) it does not require scientifically qualified personnel for operation reducing labor costs included for virus testing.

The ACE-2 protein is bound to the surface of cells and serves as an entry receptor for SARS-CoV-2 [31] . To this end, we first generated a soluble form of ACE-2, by introducing a stop codon at the C-terminal position of the extracellular domain (at amino acid position 741). This domain was linked to the Fc region of human IgG1 ( Fig. 2 (a) ), which allows purification of the chimeric protein using Protein A-coated beads and renders the protein dimeric. A thrombin cleavage site was introduced between the ACE-2 and the Fc segment for removal of the latter after purification [32] . Molecular weight and purity of the chimeric protein was validated by silver staining of samples analyzed by polyacrylamide gel electrophoresis ( Fig. 2(b) ). To determine the ability of the ACE-2-Fc probe to detect spike, we used a cell-based enzyme-linked immunosorbent assay (ELISA) [33, 34] . For this purpose, we transfected human osteosarcoma (HOS) cells with a plasmid that expresses the SARS-CoV-2 spike protein. Cells were then incubated with soluble ACE-2 and its binding was detected using a horseradish peroxidaseconjugated secondary antibody and measured by luminescence. The limit of detection for binding of ACE-2-Fc to the spike-expressing cells was 12.5 ng/mL (96.2 pM) ( Fig. 2(c) ).

To quantify the ability of the ACE-2-activated vSiNWs to detect spike, we also generated a soluble form of the spike protein. It is composed of the ectodomain of spike (amino acids 1-1211), a Thrombin cleavage site, and the Fc region of human IgG1 ( Fig. 2(d) ). To maintain subunits S1 and S2 of spike associated, we abrogated the furin cleavage site at positions 682-685 by substituting the existing Arg-Arg-Ala-Arg cleavage motif to Ser-Ser-Ala-Ser. Binding efficiency of the chimeric Spike-Fc construct to ACE-2 was measured by cell-based ELISA using HOS cells transfected with ACE-2. As shown in Fig, 2 (e), binding of Spike-Fc to the ACE-2-expressing cells was detected at a concentration as low as 0.4 ng/mL (2.3 pM). We note J o u r n a l P r e -p r o o f that viral loads in the upper airways during early stages of infection are ~10 6 -10 9 RNA copies per mL [35] . Assuming 30 spikes per virion [36] , this corresponds to 0.05-50 pM of spike protein.

Thus, the detection limit of the Spike-Fc probe using the cell-based ELISA system is within this range.

For testing the vSiNW sensor, two types of proteins were prepared. Spike proteins were prepared and used for the specific binding with the ACE-2 on the functionalized sensor surface. Bovine serum albumin (BSA) was used as a disturber for the specificity test, because its structure is analogous to that of the human serum albumin (HSA) [37] . Both BSA and spike were dissolved in the phosphate-buffered saline (PBS) at a serum-like pH of 7.4, and the concentration of all PBS solutions was 0.1x giving a sufficiently high Debye length of around 2.4 nm [38] . An isoelectric point (pI) study of the spike protein [39] showed that it has a pI of around 5, which means it applied a substantial negative potential in PBS.

The photo and schematic of the vSiNW sensor are shown in Fig.s 1 (b) and (c), respectively. For further details on the biosensor fabrication process, please refer to sections S1-S4 of the Supporting Information document. Briefly, a n + -p junction was formed on the front side of a lightly doped p-type Si substrate. The vSiNWs were turned into a highly-doped n + -emitter using ammonium dihydrogen phosphate (NH 4 H 2 PO 4 , ADP), a phosphorous (P) dopant of Si [40] . The back side of the Si substrate was highly p-doped via an aluminum (Al) based back surface field.

After biosensor fabrication, the resulting vSiNWs were ~350 nm in length with a density of around 10 10 SiNWs per cm 2 area (see Fig. S1 ). The sensing area was 6.2 mm by 6.2 mm, and the top contact was silver (Ag) based and the back contact of the sensor is Ag-coated Al. On the front side, the Ag-contact and Si area outside the sensing area was coated with sputtered dielectric materials, namely silicon dioxide (SiO x ) and silicon nitride (SiN x ) to minimize degradation of the Ag-contact during biosensor functionalization steps.

We designed a 3D-printed mount for testing the biosensors such that sufficient volume of the spike solution can be maintained on the front surface of the biosensor. The 3D-printed mount was made of two acrylonitrile butadiene styrene (ABS) plastic accessories and attached to the J o u r n a l P r e -p r o o f front and back sides of the vSiNW biosensor to form a cuvette that could contain a maximum of 250 μl of liquid on the sensing area, as shown in Fig. 1(d) . Polytetrafluoroethylene (PTFE) tapes were inserted between the top plastic part and the vSiNW sensor for fluid leak proofing.

Biosensor characterization was performed on a benchtop Keithley 2400 source meter unit (SMU) without illumination, as in Fig. 1(e) . Front and back contacts of the sensor were extended by copper (Cu) tape for contacting with the probes connected to the SMU inputs and outputs. The After that, the PBS was extracted, and 150 μl of testing solution was added, followed by an immediate measurement of the I(V) curve, denoted by I 0min (V). Then after each 20 min, an I(V) curve was measured until one hour after the addition of the testing solution, which generated three I(V) curves, I 20min (V), I 40min (V), and I 60min (V). The electrical response of the sensor was then determined by the normalized I(V) change before and one hour after the addition of the testing solution, denoted by ΔI% and defined by:

Equation (1) shows that the first and last of the six I(V) curves were used to determine ΔI%, while the other four were plotted to illustrate the gradual change of the I(V) curves from 0 min to 60 min. respectively. In addition, two other spike concentrations were tested, 0.06 μg/ml and 1.5 μg/ml, with one sensor at each concentration, and BSA was also added in those solutions to maintain the same density of molecules as the 7.5 μg/ml solution.

Devices with a p-n junction can be described using the Shockley equation for the diode model [41] , from which the effective ideality factor n eff can be approximated. However, using the measured I(V) curve of a vSiNW biosensor, it was found that the effective ideality factor n eff as a function of V exhibits a "hump" that is much greater than two, under forward bias (Fig. S3) . This effect indicates an enhanced front surface recombination that has been previously documented on nanotextured Si solar cells [42] . As a result, a "hump" diode, in addition to the traditional diffusion-and recombination-related diodes due to the p-n junction is induced, and the dark current model of device can be described using three diodes, referred as the three-diode model ( Fig. 3(a) ) [43, 44] . A possible source of each component of the three-diode model can be found in Fig. 3(b) . The two diodes D 1 and D 2 are caused by the p-n junction-related current, and the R s and R sh are the equivalent series and shunt resistances. The third diode D H , the "hump" diode, is due to the surface recombination-related saturation current I 0H .The diode is also connected in In order to further demonstrate and find the major source of variation in the vSiNW sensor caused by a change in surface potential, a water-gate experiment was conducted by simulating J o u r n a l P r e -p r o o f the electrostatic potential of the spike protein using an external voltage source (see section S7 of Supporting Information), from which it has been found that the change in I 0H is dominating, and for negative (positive) surface potential, the I 0H increases (decreases) due to surface depletion (passivation) effect, and it is also roughly found that V cutoff ≈ 300 mV.

Given the analysis above, the vSiNW biosensor can then be tested with spike and BSA testing solutions. Theoretically, if the ACE-2 or (and) the spike is missing in the experiment, the nonspecific binding of ACE-2-BSA, BSA-spike, or BSA-BSA will not induce randomly oriented electrostatic potential on the surface, hence the change of I(V) curves will be negligible. As for the specific binding of ACE-2 and spike proteins, net negative surface potential will be applied on the surface, which enhances the surface recombination effect of the n + -type vSiNW and emitter and also increases I 0H . This effect has been found on the AS sensors, as the I(V) change of an AS sensor from I PBS to I 60min is presented in Fig. 4(a) . When the incubation time increases, the sensor shows a clear increase in I, and after 1 hour, an increase in I(V) of an order of magnitude is observed at V < 0.3 V, indicating a substantial increase in I 0H induced by the negative surface potential. As a comparison, a BB sensor shows only has a small change in its I(V) curve after 1 hour in the BSA solution ( Fig. 4(b) ). The I(V) curves are then calibrated to eliminate the effects of R s and R sh , as in Fig.s 4(c) and (d) , from which the conclusion can be drawn that the I 0H has increased on the AS sensor whereas the increase is less significant on the BB sensor.

For each sensor in the experiment, ΔI D % is calculated using Eq. (4). Although from Fig. 4 and the water-gate experiment (Fig. S4) , all the values of ΔI D % at V D < 300 mV can be used for demonstration, in this work, we choose to use ΔI D % at V D = 100 mV. The main reason is that due to the limitation of the source meter, the low current values of sensors at -0.4 V < V D < 0.1 V are noisy (such as in Fig. 4(c) ). Besides, the estimation of R s and R sh could have uncertainties due to measurement errors, hence the ΔI D % values at low biases are still more reliable than those at high biases. ΔI D % at 100 mV of all the sensors for specificity experiment are presented in Furthermore, by testing at two more concentrations of the spike solution, ΔI D % at 100 mV at those concentrations are plotted in Fig. 5(b) . The data for 0 ng/ml corresponds to the AB functionalization scheme in Fig. 5(a) , which is a good negative control for the sensor. By analyzing the other groups with spike concentrations higher than zero, a semi-logarithmic relation between the concentration and ΔI D % is found, which has been theoretically demonstrated by Nair et al. [46] The regression equation indicates a strong ΔI D % response of 93.10% per decade increase of concentration, hence the sensitivity or the resolution of concentration is high in the semi-log region. The ΔI D % is close to zero at 100 ng/mL or 575 pM (ng/mL to pM conversion is explained above in Section 2.1) of spike protein, which defines the limit-of-detection (LOD) for our biosensor. This LOD is significantly higher than some other reported works [15] for ACE2 receptor-based biosensors and lower than others [13] . Therefore, we have successfully demonstrated a proof-of-principle for a vSiNW based biosensor platform for sensitive and selective detection of SARS-CoV-2. Future efforts will involve utilizing antibodies instead of ACE2 as the receptor for the spike protein given antibodies have many fold higher binding affinity to the protein than ACE2 [47] , which would result in significantly improved sensitivity and LOD of our biosensor platform.

In 

The explosion of new coronavirus tests that could help to end the pandemic

Detecting the Coronavirus (COVID-19)

Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis

False-negative results of initial RT-PCR assays for COVID-19: A systematic review

False Negative Tests for SARS-CoV-2 Infection -Challenges and Implications

Interpreting a covid-19 test result

Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure

Interim Guidance for Antigen Testing for SARS-CoV

The Good, the Bad and the Ugly: Getting CLIA-Certification for a Basic Research Lab

Antigen-detection in the diagnosis of SARS-CoV-2 infection

Scaling up COVID-19 rapid antigen tests: promises and challenges

Human ACE2-Functionalized Gold "Virus-Trap" Nanostructures for Accurate Capture of SARS-CoV-2 and Single-Virus SERS Detection

SARS-CoV-2 Variant Screening Using a Virus-Receptor-Based Electrical Biosensor

A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2)

Rapid SARS-CoV-2 Spike Protein Detection by Carbon Nanotube-Based Near-Infrared Nanosensors

COVID-19 diagnosis by SARS-CoV-2 Spike protein detection in saliva using an ultrasensitive magneto-assay based on disposable electrochemical sensor

Alsteens, Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor

SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity

Silicon nanowire biosensors for detection of cardiac troponin I (cTnI) with high sensitivity

Silicon nanowire biosensor and its applications in disease diagnostics: A review

Surface Modifying Doped Silicon Nanowire Based Solar Cells for Applications in Biosensing

Assembly and integration of semiconductor nanowires for functional nanosystems

Fabrication of silicon nanowire devices for ultrasensitive, label-free, real-time detection of biological and chemical species

Controlled growth of Si nanowire arrays for device integration

Vapor-Liquid-Solid Mechanism of Single Crystal Growth ( New Method Growth Catalysis from Impurity Whisker Epitaxial + Large Crystals Si E )

Metal assisted catalyzed etched (MACE) black Si: optics and device physics

Nanostructured silicon via metal assisted catalyzed etch (MACE): chemistry fundamentals and pattern engineering

Structural basis of receptor recognition by SARS-CoV-2

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

Design considerations of silicon nanowire biosensors

Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19

An overview of enzymatic reagents for the removal of affinity tags

Induction of a Tier-1-Like Phenotype in Diverse Tier-2 Isolates by Agents That Guide HIV-1 Env to Perturbation-Sensitive, Nonnative States

Accurate predictions of population-level changes in sequence and structural properties of HIV-1 Env using a volatility-controlled diffusion model

Virological assessment of hospitalized patients with COVID-2019

Structures, conformations and distributions of SARS-CoV-2 spike protein trimers on intact virions, bioRxiv

Effects of buffer composition and dilution on nanowire field-effect biosensors

Isoelectric point determination by imaged CIEF of commercially available SARS-CoV-2 proteins and the hACE2 receptor

Performance enhancement techniques for the front and back of nanostructured "black silicon" solar cells

The theory of p-n junctions in semiconductors and p-n junction transistors

Humps, a surface damage explanation, 2nd World Conference and Exhibition on Photovoltaic Solar Energy Conversion

Lumps, humps and bumps : three detrimental effects in the current-voltage curve of silicon solar cells

On effective surface recombination parameters

Physics of semiconductor devices

Screening-Limited Response of NanoBiosensors

The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humans